Navalign LLC
BSX icon

Navalign LLC’s Boston Scientific BSX Stock Holding History

Navalign LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$599K Buy
13,718
+2,129
+18% +$98.6K 0.14% 85
2026
Q2 		$495K Buy
11,589
+1,054
+10% +$57.2K 0.12% 91
2026
Q1 		$661K Buy
10,535
+416
+4% +$33.3K 0.17% 80
2025
Q4 		$965K Buy
10,119
+242
+2% +$23.7K 0.24% 68
2025
Q3 		$964K Sell
9,877
-199
-2% -$20.6K 0.25% 66
2025
Q2 		$1.08M Sell
10,076
-1,174
-10% -$119K 0.3% 58
2025
Q1 		$1.13M Sell
11,250
-543
-5% -$54.7K 0.32% 54
2024
Q4 		$1.05M Sell
11,793
-251
-2% -$22.1K 0.31% 55
2024
Q3 		$1.01M Sell
12,044
-385
-3% -$30.3K 0.3% 56
2024
Q2 		$957K Sell
12,429
-20
-0.2% -$1.46K 0.3% 55
2024
Q1 		$853K Sell
12,449
-374
-3% -$24K 0.28% 64
2023
Q4 		$741K Sell
12,823
-292
-2% -$15.6K 0.26% 71
2023
Q3 		$692K Sell
13,115
-490
-4% -$25.7K 0.26% 79
2023
Q2 		$736K Sell
13,605
-714
-5% -$37.3K 0.29% 64
2023
Q1 		$716K Sell
14,319
-289
-2% -$13.6K 0.3% 68
2022
Q4 		$676K Sell
14,608
-802
-5% -$34.7K 0.28% 77
2022
Q3 		$597K Buy
15,410
+616
+4% +$24.7K 0.27% 78
2022
Q2 		$551K Sell
14,794
-24
-0.2% -$977 0.24% 78
2022
Q1 		$638K Buy
14,818
+571
+4% +$24.7K 0.27% 74
2021
Q4 		$605K Buy
14,247
+227
+2% +$9.5K 0.24% 87
2021
Q3 		$608K Sell
14,020
-31
-0.2% -$1.37K 0.26% 85
2021
Q2 		$601K Buy
14,051
+938
+7% +$39.5K 0.25% 82
2021
Q1 		$507K Buy
+13,113
New +$496K 0.22% 91

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Navalign LLC's BSX Position: Q3 2026 in Review

Navalign LLC increased its Boston Scientific (BSX) stake by 18% in Q3 2026, buying an estimated $98.6K and bringing the position to 13,718 shares worth $599K. The position accounts for 0.14% of the portfolio, ranked #85.

Navalign LLC first reported a position in BSX in Q1 2021 and has held it in 23 quarters since. The position peaked at $1.13M in Q1 2025. 922 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Navalign LLC held 13,718 shares of Boston Scientific worth $599K as of Q3 2026.
  • Navalign LLC bought 2,129 Boston Scientific shares in Q3 2026, an estimated $98.6K.
  • Boston Scientific made up 0.14% of Navalign LLC's portfolio in Q3 2026, its #85 holding.
  • Navalign LLC first reported a position in Boston Scientific in Q1 2021 and has held it in 23 quarters since.
  • Navalign LLC's Boston Scientific position peaked at $1.13M in Q1 2025.
  • 922 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Navalign LLC's 13F filing for Q3 2026, filed 9 Nov 2026.